Serial #79419569
LIVE

Serial Number

79419569

Owner

TAIHO PHARMACEUTICAL CO., LTD.

Attorney

Norm J. Rich

Filing Date

Jan 23, 2025

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79419569 Trademark

Serial Number: 79419569 • Registration: 8309268

Serial #79419569 is a trademark filed by TAIHO PHARMACEUTICAL CO., LTD. on January 23, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

TAIHO PHARMACEUTICAL CO., LTD. (107 trademarks)

CHIYODA-KU, TOKYO , JP

Entity Type: 03

Trademark Details

Filing Date

January 23, 2025

Registration Date

June 23, 2026

Published for Opposition

May 5, 2026

Goods & Services

Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; tumor suppressing agents; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for treating hematological disorders; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines being anti-emetic preparations; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations; chemical reagents for medical purposes in the field of oncology.

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 23, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 23, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 5, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 5, 2026 PUBO
NOTIFICATION PROCESSED BY IB
Apr 30, 2026 GPNX
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 29, 2026 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 15, 2026 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 15, 2026 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 3, 2026 CNSA
ASSIGNED TO EXAMINER
Mar 5, 2026 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 4, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 4, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 4, 2025 TROA
REFUSAL PROCESSED BY IB
Nov 30, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 10, 2025 RFCS
REFUSAL PROCESSED BY MPU
Nov 10, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 24, 2025 RFCR
NON-FINAL ACTION WRITTEN
Sep 23, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 2, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 28, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 28, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 25, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 20, 2025 REPR